Non Invasive Prenatal Testing (NIPT)
During pregnancy, some fragments of the foetal DNA circulate in the maternal blood and are detectable starting from the 7th week of gestation. The circulating foetal DNA quantity increases with the increasing gestational period, and from the 9th or 10th week of gestation it is sufficient to guarantee a highly specific and sensitive result of the non-invasive prenatal screening tests.
Non-invasive prenatal testing offers early genetic screening for chromosomal conditions using a sample of maternal blood.
The tests screen for chromosomal abnormalities in the foetus, for example, the presence of whole extra chromosome (trisomy) such as Down Syndrome, Edwards Syndrome, Patau Syndrome, Trisomy X, Klinefelter Syndrome, and Jacobs Syndrome, or absence of whole chromosomes (monosomy), such as Turner Syndrome.
NIPT eliminates any risk of miscarriage, or other adverse outcomes that are associated with invasive testing procedures such as amniocentesis or chorionic villus sampling (CVS)
HOW IT WORKS:
- Patient decides to take the test.
- Patient or physician orders the test kit online.
- The NIPT kit is shipped to the address provided by patient or physician.
- Patient proceeds to blood draw, the request form and informed consent form are completed by patient and physician.
- Blood sample and test request form are sent back to lab on the same day as blood draw.
- Lab processes and analyses the sample.
- Test results are sent to the requesting physician.
BEFORE ORDERING AND PAYING FOR THE TEST AND KIT, PLEASE ENSURE THAT YOUR PHYSICIAN IS ABLE TO SUPPORT YOU IN THE NIPT PROCESS.
All NIPT requests must be accompanied by their specific patient consent and information forms which you will receive together with the test kit.
TO ORDER YOUR TEST KIT CLICK HERE
Important: Non-invasive prenatal tests are screening tests and do not provide a definitive diagnosis.